Other News To Note
Monday, January 24, 2011
Pfizer Inc., of New York, extended its tender offer for King Pharmaceuticals Inc., of Bristol, Tenn., to Jan. 28, 2011. Pfizer agreed to buy King in October for $14.25 per share, or about $3.6 billion.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.